<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>One of common pathophysiological states associated with central <z:mp ids='MP_0008912'>nervous</z:mp> system is <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C1695782" disease_type="Disease or Syndrome" abbrv="">cerebral hypoperfusion</z:e> (CH) that frequently occurs in conditions such as vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> and <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Long term blockage of <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi> type 1 (AT(1)) receptor provides protection from <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> induced injury of brain as well as reduction of cerebrovascular <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Examining effect of the blockage on reduced <z:chebi fb="0" ids="16856">glutathione</z:chebi> (GSH), <z:chebi fb="6" ids="22652,29073">ascorbic acid</z:chebi> (AA), and <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation were of purpose in the present study </plain></SENT>
<SENT sid="3" pm="."><plain>Modeling CH, rats were subjected to permanent occlusion of common carotid arteries bilaterally </plain></SENT>
<SENT sid="4" pm="."><plain>AT(1 )receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, <z:chebi fb="0" ids="3347">candesartan</z:chebi>, was given daily for 14 days after surgery </plain></SENT>
<SENT sid="5" pm="."><plain>CH caused a significant increase in <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation and decrease in GSH content of cerebral hippocampal tissue with no change in AA level </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="3347">Candesartan</z:chebi> (0.5 mg/kg, oral) not only reduced <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation but also restored GSH significantly besides elevating AA and improving histopathological alterations </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, long term AT(1 )receptor blockage may be considered as novel therapeutic approach for protection from damage associated with CH </plain></SENT>
<SENT sid="8" pm="."><plain>Underlying mechanism(s) may in part be related to suppressing <z:mp ids='MP_0003674'>oxidative stress</z:mp> and preserving brain <z:chebi fb="11" ids="22586">antioxidant</z:chebi> capacity </plain></SENT>
</text></document>